Are you a wet-lab or computational scientist working on #cancer? Then the Cell Model Passports (CMP) from the @DepMapSanger @sangerinstitute is a resource you need to know about.

Don't miss your chance to register for the GRC conference on Synthetic Lethality Approaches in Oncology this July in beautiful Maine (near Boston). We have stellar speakers with a mix from academia and industry in this translational space. There are speaker slots from abstracts.

For students & trainees, there are speaking slots for selected abstracts at the upcoming GRC conference on Synthetic Lethality in Oncology (. The informal meeting format is perfect for networking to find your next career opportunity. Bursaries available.

RT @cnsdincer: 🚨 Excited to share our latest preprint!.@Garnettlab @MatthewACoelho .We introduce BEstimate, a flexible, comprehensive tool….

Check out the first session for the upcoming GRC conference on synthetic lethality in oncology Top flight speakers - Simon Powell (MSK), Chris Lord (ICR), and plenary talk from William Sellers (Broad Inst.). There's still time to register.

RT @draparente: If I wanted to design a mini binder protein that binds to a known small molecule, what’s the SotA model to use right now?.

Speakers will be discussing new and existing targets (PARP, WRN, POL-theta, MTAP, CDK12), new technologies (organoids, CRISPR, in vivo screening, prime editing), new concepts such as activation lethality, clinical translation and use of AI/ML to predict synthetic-lethality.

Learn about the future of synthetic lethality in oncology at the upcoming #GRC. This is the inaugural meeting and WOW what a line up! It is a phenomenal program, with top speakers from academia and industry. Check it out! #depmapsanger #cancerdepmap.

New Gordon Research Conference Alert: Synthetic Lethality Approaches in Oncology. Join us 20-25th July 2025 for an intimate meeting with thought leaders in the field. Great for networking and opportunities for early career scientists to present.

RT @olivier_belli: 🚨 Very happy to announce the publication of my PhD work @NatureBiotech where we combined base and prime editing screens….

RT @imartincorena: Excited to share our latest work. We introduce an improved version of NanoSeq, a duplex sequencing protocol with <5 erro….

RT @R_Rahbari: My old account has disappeared, and I'm not sure why. I’m hoping to recover it somehow or link it to my new one! Thank you t….

RT @MDC_Neville: Excited to share our new preprint in which we address:.(1) Accurate sequencing of sperm at scale.(2) Positive selection of….

RT @lapassmore: We have an open #postdoc position to study the molecular mechanisms of #DNArepair !🧬🔬.The project will build on recent find….

RT @KarunaMDPhD: Thrilled to share our paper now out @Nature delineating #plasticity during #CRC #metastasis, a fantastic collaboration led….

RT @IPuigBorreil: A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogenei….

RT @Sandra_Misale: Be WRNed! @GabrielePicco2 rocking the stage at #ENAsymp24! Amazing work done and more to come!

RT @CRUK_CI: We are hiring a core-funded Group Leader working in Artificial Intelligence! . The position comes with a flexible start-up pac….

RT @GabrielePicco2: Just arrived in Barcelona for #ENA2024! Looking forward to presenting our research on MSI cancer cell evolution under s….

Congratulation Annie. Wonderful work and a delightful collaboration.

Delighted to share our work in @NatureGenet using base editing to map genetic mechanisms of drug resistance. If you're interested in drug discovery then check it out. Access here [. Congratulations to the team and @MatthewACoelho.